Table 1.
Baseline characteristics of CAH-related stroke patients
| Total (n = 73) | |
|---|---|
| Age, years, median (IQR) | 70 (66–77) |
| Women, n (%) | 38 (52) |
| Hypertension, n (%) | 24 (33) |
| Dyslipidemia, n (%) | 16 (22) |
| Diabetes mellitus, n (%) | 12 (16) |
| Current smoking, n (%) | 12 (16) |
| Deep venous thrombosis, n (%) | 26 (36) |
| Pancreas cancer, n (%) | 22 (30) |
| Lung cancer, n (%) | 14 (19) |
| Gastric cancer, n (%) | 9 (12) |
| Ovarian cancer, n (%) | 7 (10) |
| Biliary tract cancer, n (%) | 6 (8) |
| Adenocarcinoma, n (%) | 52 (71) |
| Squamous cell carcinoma, n (%) | 4 (5) |
| Systemic metastases, n (%) | 65 (89) |
| Recent chemotherapy, n (%) | 27 (37) |
| DWI three territory sign, n (%) | 57 (78) |
| Pretreatment D-dimer level, μg/mL, median (IQR) | 22.8 (11.9–34.2) |
IQR, interquartile range; DWI, diffusion-weighted imaging.